-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Colorectal cancer (CRC) is the third most common cancer in the world and the second leading cause of cancer death
.
It has been reported that compared with women, men have a higher risk of developing CRC, and women have a 25% lower risk of CRC mortality than men
colorectal cancer
Substantial evidence suggests that dysbiosis of gut microbial communities is associated with colorectal tumors
.
Recently, a research article was published in the British Journal of Cancer, an authoritative journal in the field of oncology.
We conducted a comprehensive literature search of the MEDLINE and EMBASE databases to identify eligible studies
.
We included observational studies exploring associations between microbial biomarkers and colorectal tumors
This meta-analysis included 45 studies to assess the association between microbial markers and colorectal tumors
.
The researchers identified nine fecal microbiota species (namely, Fusobacterium, Enterococcus, Porphyromonas, Salmonella, Pseudomonas, Peptostreptococcus , Actinomyces, Bifidobacterium, and Rosetella spp.
Digestion
Thus, this review provides evidence supporting the association between different types of microbial species and their perspective on their predictive value for colorectal tumors
.
Predictive models developed from case-control studies require further external validation in high-quality prospective studies
This review provides evidence supporting the association between different types of microbial species and their predictive value for colorectal tumors
Original source:
Lili Yu.